Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for AstraZeneca plc > News item |
Fitch affirms AstraZeneca
Fitch Ratings said it affirmed AstraZeneca plc's long-term issuer default rating and senior unsecured rating at BBB+.
The outlook remains stable.
“Our affirmation reflects our confidence that AZ's resumption of growth since 2H18, when its new drug portfolio began to offset the decline of its off-patent drugs, should be sustainable, enabling healthy organic revenue growth over 2019-2022,” the agency said in a news release.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.